全文获取类型
收费全文 | 137篇 |
免费 | 8篇 |
出版年
2021年 | 5篇 |
2020年 | 3篇 |
2018年 | 1篇 |
2017年 | 2篇 |
2016年 | 2篇 |
2015年 | 8篇 |
2014年 | 7篇 |
2013年 | 12篇 |
2012年 | 6篇 |
2011年 | 7篇 |
2010年 | 5篇 |
2009年 | 5篇 |
2008年 | 5篇 |
2007年 | 9篇 |
2006年 | 9篇 |
2005年 | 7篇 |
2004年 | 5篇 |
2003年 | 7篇 |
2002年 | 5篇 |
2001年 | 11篇 |
2000年 | 3篇 |
1999年 | 5篇 |
1993年 | 2篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 3篇 |
1985年 | 2篇 |
1984年 | 1篇 |
1982年 | 2篇 |
1974年 | 1篇 |
排序方式: 共有145条查询结果,搜索用时 15 毫秒
91.
Yuan Xue Jossef Osborn Anand Panchal Jay L. Mellies 《Applied and environmental microbiology》2015,81(11):3766-3774
Zinc supplements are an effective clinical treatment for infantile diarrheal disease caused by enteric pathogens. Previous studies demonstrated that zinc acts on enteropathogenic Escherichia coli (EPEC) bacteria directly to suppress several virulence-related genes at a concentration that can be achieved by oral delivery of dietary zinc supplements. Our in vitro studies showed that a micromolar concentration of zinc induced the envelope stress response and suppressed virulence in EPEC, providing a possible mechanistic explanation for zinc''s therapeutic action. In this report, we investigated the molecular and physiological changes in EPEC induced by zinc. We found that micromolar concentrations of zinc reduced the bacterial growth rate without affecting viability. We observed increased membrane permeability caused by zinc. Zinc upregulated the RpoE-dependent envelope stress response pathway and suppressed EPEC virulence gene expression. RpoE alone was sufficient to inhibit virulence factor expression and to attenuate attaching and effacing lesion formation on human host cells. By mutational analysis we demonstrate that the DNA-binding motif of RpoE is necessary for suppression of the LEE1, but not the LEE4, operon. Predictably, inhibition of the RpoE-mediated envelope stress response in combination with micromolar concentrations of zinc reduced EPEC viability. In conclusion, zinc induces the RpoE and stress response pathways in EPEC, and the alternate sigma factor RpoE downregulates EPEC LEE and non-LEE virulence genes by multiple mechanisms. 相似文献
92.
Background
State-of-the-art signal processing methods are known to detect information in single-trial event-related EEG data, a crucial aspect in development of real-time applications such as brain computer interfaces. This paper investigates one such novel approach, evaluating how individual classifier and feature subset tailoring affects classification of single-trial EEG finger movements. The discrete wavelet transform was used to extract signal features that were classified using linear regression and non-linear neural network models, which were trained and architecturally optimized with evolutionary algorithms. The input feature subsets were also allowed to evolve, thus performing feature selection in a wrapper fashion. Filter approaches were implemented as well by limiting the degree of optimization. 相似文献93.
Jonathan Coffman Bruno Marques Raquel Orozco Minni Aswath Hasan Mohammad Eike Zimmermann Joelle Khouri Jan Griesbach Saeed Izadi Ambrose Williams Kannan Sankar Benjamin Walters Jasper Lin Stefan Hepbildikler John Schiel John Welsh Gisela Ferreira Jared Delmar Neil Mody Christopher Afdahl Tingting Cui Rushd Khalaf Alexander Hanke Lars Pampel Siddharth Parimal Xuan Hong Ujwal Patil Jennifer Pollard Francis Insaidoo Julie Robinson Divya Chandra Marco Blanco Jainik Panchal Soundara Soundararajan David Roush Nihal Tugcu Steven Cramer Charles Haynes Richard C. Willson 《Biotechnology and bioengineering》2020,117(7):2100-2115
94.
Anjoy Majhi Ghazi M. Rahman Shyam Panchal Joydip Das 《Bioorganic & medicinal chemistry》2010,18(4):1591-1598
Protein kinase C (PKC) is a family of serine/threonine kinases that play a central role in cellular signal transduction. The second messenger diacylglycerol having two long carbon chains acts as the endogenous ligand for the PKCs. Polyphenol curcumin, the active constituent of Curcuma longa is an anti-cancer agent and modulates PKC activity. To develop curcumin derivatives as effective PKC activators, we synthesized several long chain derivatives of curcumin, characterized their absorption and fluorescence properties and studied their interaction with the activator binding second cysteine-rich C1B subdomain of PKCδ, PKCε and PKCθ. Curcumin (1) and its C16 long chain analog (4) quenched the intrinsic fluorescence of PKCδC1B, PKCεC1B and PKCθC1B in a manner similar to that of PKC activator 12-O-tetradecanoylphorbol 13-acetate (TPA). The EC50s of the curcumin derivatives for fluorescence quenching varied in the range of 4–11 μM, whereas, EC50s for TPA varied in the range of 3–6 μM. Fluorescence emission maxima of 1 and 4 were blue shifted and the fluorescence anisotropy values were increased in the presence of the C1B domains in a manner similar to that shown by the fluorescent analog of TPA, sapintoxin-D, confirming that they were bound to the proteins. Molecular docking of 1 and 4 with novel PKC C1B revealed that both the molecules form hydrogen bonds with the protein residues. The present result shows that curcumin and its long chain derivatives bind to the C1B subdomain of novel PKCs and can be further modified structurally to improve its binding and activity. 相似文献
95.
96.
Krishna P. Kota Veronica Soloveva Laura M. Wanner Glenn Gomba Erkan Kiris Rekha G. Panchal Christopher D. Kane Sina Bavari 《Journal of visualized experiments : JoVE》2014,(93)
Synaptosomal-associated protein-25 (SNAP-25) is a component of the soluble NSF attachment protein receptor (SNARE) complex that is essential for synaptic neurotransmitter release. Botulinum neurotoxin serotype A (BoNT/A) is a zinc metalloprotease that blocks exocytosis of neurotransmitter by cleaving the SNAP-25 component of the SNARE complex. Currently there are no licensed medicines to treat BoNT/A poisoning after internalization of the toxin by motor neurons. The development of effective therapeutic measures to counter BoNT/A intoxication has been limited, due in part to the lack of robust high-throughput assays for screening small molecule libraries. Here we describe a high content imaging (HCI) assay with utility for identification of BoNT/A inhibitors. Initial optimization efforts focused on improving the reproducibility of inter-plate results across multiple, independent experiments. Automation of immunostaining, image acquisition, and image analysis were found to increase assay consistency and minimize variability while enabling the multiparameter evaluation of experimental compounds in a murine motor neuron system. 相似文献
97.
Garde S Fraser JE Nematpoor N Pollex R Morin C Forté A Rabbani S Panchal C Gupta MB 《Protein expression and purification》2007,54(2):193-203
Human PSP94 (prostate secretory protein of 94 amino acids) is a major protein synthesized by the prostate gland and secreted in large quantities in seminal fluid. Previous studies have suggested a potential biomedical utility of PSP94 in applications such as diagnosis/prognosis and in treatment of human prostate cancer (PCa). This study was designed to produce a recombinant human PSP94 (rPSP94) to evaluate its clinical and functional role in PCa. We cloned PSP94 cDNA and successfully expressed an active recombinant protein in yeast using Pichia pastoris expression system. A simple purification strategy was established that incorporated combination of membrane ultrafiltration (Pellicon tangential-flow system) and anion exchange chromatography using DE52 resin. The method minimized the technical level of expertise for the production of high quality functional protein. The purified rPSP94 (>98% purity) showed a single band with SDS-PAGE analysis and a peak with a molecular mass (M(r)) of 11,495 kDa using MALDI TOF mass spectrometry (MS). The in vitro competitive binding assays indicated high functional similarity of the rPSP94 with that of its native counterpart. Furthermore, in vivo administration of rPSP94 caused a significant growth inhibition of hormone refractory Mat LyLu tumors in Dunning rat model. Taken together, our data provides evidence for high suitability of the purified rPSP94 for evaluation of its potential diagnostic and therapeutic role in PCa and as a valuable analytical reference standard for clinical studies. 相似文献
98.
Burnett JC Ruthel G Stegmann CM Panchal RG Nguyen TL Hermone AR Stafford RG Lane DJ Kenny TA McGrath CF Wipf P Stahl AM Schmidt JJ Gussio R Brunger AT Bavari S 《The Journal of biological chemistry》2007,282(7):5004-5014
An efficient research strategy integrating empirically guided, structure-based modeling and chemoinformatics was used to discover potent small molecule inhibitors of the botulinum neurotoxin serotype A light chain. First, a modeled binding mode for inhibitor 2-mercapto-3-phenylpropionyl-RATKML (K(i) = 330 nM) was generated, and required the use of a molecular dynamic conformer of the enzyme displaying the reorientation of surface loops bordering the substrate binding cleft. These flexible loops are conformationally variable in x-ray crystal structures, and the model predicted that they were pivotal for providing complementary binding surfaces and solvent shielding for the pseudo-peptide. The docked conformation of 2-mercapto-3-phenylpropionyl-RATKML was then used to refine our pharmacophore for botulinum serotype A light chain inhibition. Data base search queries derived from the pharmacophore were employed to mine small molecule (non-peptidic) inhibitors from the National Cancer Institute's Open Repository. Four of the inhibitors possess K(i) values ranging from 3.0 to 10.0 microM. Of these, NSC 240898 is a promising lead for therapeutic development, as it readily enters neurons, exhibits no neuronal toxicity, and elicits dose-dependent protection of synaptosomal-associated protein (of 25 kDa) in a primary culture of embryonic chicken neurons. Isothermal titration calorimetry showed that the interaction between NSC 240898 and the botulinum A light chain is largely entropy-driven, and occurs with a 1:1 stoichiometry and a dissociation constant of 4.6 microM. 相似文献
99.
Daniel CB Jeffery Naoko Kakusho Zhiying You Marlene Gharib Brandon Wyse Erin Drury Michael Weinreich Pierre Thibault Alain Verreault Hisao Masai Krassimir Yankulov 《Cell cycle (Georgetown, Tex.)》2015,14(1):74-85
Chromatin Assembly Factor I (CAF-I) plays a key role in the replication-coupled assembly
of nucleosomes. It is expected that its function is linked to the regulation of the cell
cycle, but little detail is available. Current models suggest that CAF-I is recruited to
replication forks and to chromatin via an interaction between its Cac1p subunit and the
replication sliding clamp, PCNA, and that this interaction is stimulated by the kinase
CDC7. Here we show that another kinase, CDC28,
phosphorylates Cac1p on serines 94 and 515 in early S phase and regulates its association
with chromatin, but not its association with PCNA. Mutations in the Cac1p-phosphorylation
sites of CDC28 but not of CDC7 substantially reduce the
in vivo phosphorylation of Cac1p. However, mutations in the putative
CDC7 target sites on Cac1p reduce its stability. The association of
CAF-I with chromatin is impaired in a cdc28–1 mutant and to a
lesser extent in a cdc7–1 mutant. In addition, mutations in the
Cac1p-phosphorylation sites by both CDC28 and CDC7
reduce gene silencing at the telomeres. We propose that this phosphorylation represents a
regulatory step in the recruitment of CAF-I to chromatin in early S phase that is distinct
from the association of CAF-I with PCNA. Hence, we implicate CDC28 in the
regulation of chromatin reassembly during DNA replication. These findings provide novel
mechanistic insights on the links between cell-cycle regulation, DNA replication and
chromatin reassembly. 相似文献
100.
Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action 总被引:1,自引:0,他引:1
Hemant Poudyal Sunil K. Panchal Vishal Diwan Lindsay Brown 《Progress in lipid research》2011,50(4):372-387
Epidemiological, human, animal, and cell culture studies show that n−3 fatty acids, especially α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), reduce the risk factors of cardiovascular diseases. EPA and DHA, rather than ALA, have been the focus of research on the n−3 fatty acids, probably due to the relatively inefficient conversion of ALA to EPA and DHA in rodents and humans. This review will assess our current understanding of the effects and potential mechanisms of actions of individual n−3 fatty acids on multiple risk factors of metabolic syndrome. Evidence for pharmacological responses and the mechanism of action of each of the n−3 fatty acid trio will be discussed for the major risk factors of metabolic syndrome, especially adiposity, dyslipidemia, insulin resistance and diabetes, hypertension, oxidative stress, and inflammation. Metabolism of n−3 and n−6 fatty acids as well as the interactions of n−3 fatty acids with nutrients, gene expression, and disease states will be addressed to provide a rationale for the use of n−3 fatty acids to reduce the risk factors of metabolic syndrome. 相似文献